Pulpotomy using Neoputty Mineral Trioxide Aggregate
ProcedurePulpotomy (Test Group): Removal of coronal pulp followed by Neoputty MTA placement and restoration.
Other names: MTA
NCT Number: NCT06929247
itle: Evaluation of Pulpotomy using Neoputty MTA vs. Pulpectomy using Metapex in Children (4-9 years).
Objective: Compare clinical and radiographic success of pulpotomy vs. pulpectomy for vital primary molars with irreversible pulpitis.
Design: Randomized controlled trial with 2-arm parallel groups.
Participants: Healthy children aged 4-9 with specific inclusion/exclusion criteria.
Outcomes: Primary (pain relief, absence of complications) and secondary (radiographic success).
Trial opening soon.
Get Notified4 year–9 year
All sexes
Interventional
Not applicable
Background and Rationale Treating irreversible pulpitis in primary molars is challenging due to complex root canal anatomy and rapid progression of pulp inflammation. Pulpectomy is the standard approach, but its technical difficulty often necessitates referral to specialists. New bioactive materials like Neoputty MTA and improved understanding of pulp biology justify reevaluation of less invasive treatments like pulpotomy. This study addresses the lack of clinical trials comparing pulpotomy with pulpectomy in cases of irreversible pulpitis in primary molars. Aim To compare the clinical and radiographic success of pulpotomy using Neoputty MTA vs. pulpectomy using Metapex in vital primary molars with symptomatic irreversible pulpitis in children aged 49 years. Hypothesis Null Hypothesis: No significant difference in treatment outcome between pulpotomy and pulpectomy.
Methodology Participants
Secondary: Pain assessment at 24 hours and 7 days post-treatment using VAS. Follow-up Timeline Evaluations at baseline, 24h, 1w, 3m, 6m, 9m, and 12m post-intervention. Randomization and Blinding Randomization via opaque sealed envelopes. Outcome assessors blinded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pulpotomy (Test Group): Removal of coronal pulp followed by Neoputty MTA placement and restoration.
Other names: MTA
pulpectomy: removal of radicular pulp followed by metapex placement and final restoration
Other names: calcium hydroxide with iodoform
Time frame: after 24h , 1week, 3 months, 6 months ,9 months and 12 months
by Visual analog scale from zero to ten. which zero is better outcome and ten is worse outcome
Time frame: after 24h , 1week, 3 months, 6 months ,9 months and 12 months
Tapping the tooth with the blunt end of the mirror
Time frame: after 24h , 1week, 3 months, 6 months ,9 months and 12 months
Clinical examination
Time frame: after 24h , 1week, 3 months, 6 months ,9 months and 12 months
Clinical examination
Time frame: after 24h , 1week, 3 months, 6 months ,9 months and 12 months
Digital periapical intraoral radiograph
Time frame: after 24h , 1week, 3 months, 6 months ,9 months and 12 months
Digital periapical intraoral radiograph
Mohamed Nashaat Mohamed
Other
Clinical and Radiographic Evaluation of Pulpotomy Using Neoputty MTA Versus Pulpectomy Using Metapex in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis in Children Aged 4 to 9 Years: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07522723
Pulpitis - Irreversible
View Trial DetailsNCT07466095
Pulpitis - Irreversible, Pulpitis - Reversible
View Trial DetailsNCT06938191
Biomarkers, Dental Pulp Diseases
View Trial DetailsNCT07230717
Dental Pulp Diseases, Dental Pulp Necrosis
View Trial Details